| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MRNS | Common Stock | Disposed to Issuer | -$6.99K | -12.7K | -84.67% | $0.55 | 2.3K | Feb 7, 2025 | Direct | F1, F2 |
| transaction | MRNS | Common Stock | Disposed to Issuer | -$1.27K | -2.3K | -100% | $0.55 | 0 | Feb 11, 2025 | Direct | F1, F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MRNS | Stock Option (Right to Buy) | Disposed to Issuer | $0 | -10.5K | -100% | $0.00 | 0 | Feb 11, 2025 | Common Stock | 10.5K | $1.40 | Direct | F4 |
| transaction | MRNS | Stock Option (Right to Buy) | Disposed to Issuer | $0 | -20.9K | -100% | $0.00 | 0 | Feb 11, 2025 | Common Stock | 20.9K | $9.74 | Direct | F4 |
| transaction | MRNS | Stock Option (Right to Buy) | Disposed to Issuer | $0 | -16.2K | -100% | $0.00 | 0 | Feb 11, 2025 | Common Stock | 16.2K | $5.94 | Direct | F4 |
| transaction | MRNS | Stock Option (Right to Buy) | Disposed to Issuer | $0 | -12.4K | -100% | $0.00 | 0 | Feb 11, 2025 | Common Stock | 12.4K | $10.40 | Direct | F4 |
| transaction | MRNS | Stock Option (Right to Buy) | Disposed to Issuer | $0 | -16.5K | -100% | $0.00 | 0 | Feb 11, 2025 | Common Stock | 16.5K | $12.60 | Direct | F4 |
| transaction | MRNS | Stock Option (Right to Buy) | Disposed to Issuer | $0 | -25K | -100% | $0.00 | 0 | Feb 11, 2025 | Common Stock | 25K | $8.28 | Direct | F4 |
| transaction | MRNS | Stock Option (Right to Buy) | Disposed to Issuer | $0 | -8.75K | -100% | $0.00 | 0 | Feb 11, 2025 | Common Stock | 8.75K | $15.84 | Direct | F4 |
| transaction | MRNS | Stock Option (Right to Buy) | Disposed to Issuer | $0 | -8.75K | -100% | $0.00 | 0 | Feb 11, 2025 | Common Stock | 8.75K | $24.76 | Direct | F4 |
| transaction | MRNS | Stock Option (Right to Buy) | Disposed to Issuer | $0 | -2.63K | -100% | $0.00 | 0 | Feb 11, 2025 | Common Stock | 2.63K | $4.84 | Direct | F4 |
| transaction | MRNS | Stock Option (Right to Buy) | Disposed to Issuer | $0 | -3.85K | -100% | $0.00 | 0 | Feb 11, 2025 | Common Stock | 3.85K | $6.92 | Direct | F4 |
H. Fischer Seth is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
| Id | Content |
|---|---|
| F1 | On December 29, 2024, the Issuer entered into an Agreement and Plan of Merger (the "Merger Agreement") with Immedica Pharma AB, a corporation organized and existing under the laws of Sweden ("Parent"), and Matador Subsidiary, Inc. a Delaware corporation and a wholly owned subsidiary of Parent ("Purchaser"). Pursuant to the terms of the Merger Agreement and the Offer (as defined in the Merger Agreement), each share of the Issuer's common stock (the "Common Stock") held by the Reporting Person was acquired, subject to adjustment, at a purchase price of $0.55 per share (the "Offer Price") in cash. |
| F2 | The reported amount reflects an adjustment to correct a clerical error that previously underreported the Reporting Person's holdings by 2,081 shares of Common Stock. No reportable transactions were omitted from previous filings in connection with the clerical error underlying this correction. |
| F3 | Represents 2,300 shares underlying Restricted Stock Units (the "RSUs"). Pursuant to the terms of the Merger Agreement, at the effective time of the merger (the "Effective Time"), each outstanding RSU was terminated in exchange for a lump sum cash payment equal to (i) the Offer Price multiplied by (ii) the number of shares of Common Stock underlying the RSU. |
| F4 | Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof. |